EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Report from the 27th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Calgary, Alberta, 26–27 September 2025: Advances in Colon and Rectal Cancer

Richard Lee-Ying, Sharlene Gill iD, Adrian Box iD, Hannah Latour, Scott Strum, Vallerie Gordon, Ralph Wong, Petra Grendarova, Tamara Gimon, Shahid Ahmed iD, Georgia Geller, Christina Kim iD und 4 weitere

Current Oncology · 21.07.2026 · 33 (7) · 437

DOI: 10.3390/curroncol33070437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, online erschienen am 21.07.2026. Verfasst von Richard Lee-Ying und 15 weiteren Autor:innen. Beteiligte Einrichtung: Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB T2N 4N1, Canada. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Amgen Canada, Astellas Pharma Canada, Bristol-Myers Squibb Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 27th annual Western Canadian Gastrointestinal Cancer Consensus Conference (WCGCCC) was held in Calgary, Alberta, on 26–27 September 2025. The WCGCCC is an interactive multidisciplinary conference that was attended by healthcare professionals from across Western Canada (British Columbia, Alberta, Saskatchewan, and Manitoba) who are involved in the care of patients with colorectal cancer. Specialists from the fields of medical and radiation oncology, pathology, surgery, and a family physician in oncology participated in presentations and discussions for the purpose of developing the recommendations presented here. This consensus statement addresses recent advances in the management of colorectal cancer in a Western Canadian context, with respect to adjuvant exercise, as per the CHALLENGE trial, adjuvant Aspirin and PI3K testing, as per the ALASCCA trial, adjuvant immunotherapy, as per the ATOMIC trial, the use of encorafenib and an EGFR inhibitor with chemotherapy, as per the BREAKWATER trial, the use of combination immunotherapy as per the CHECKMATE 8HW trial and optimal strategies for omitting radiation and non-operative management of non-metastatic rectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsHumansCanadaAlberta

Stichwörter der Autor:innen

BRAF V600EMSI-HPI3K pathway mutationsadjuvant therapycolon cancercolorectal cancerdMMRdeficient mismatch repairimmune checkpoint inhibitorsimmunotherapymetastatic colorectal cancermicrosatellite instability–highnonoperative managementrectal cancerstructured exercise intervention

Autor:innen und Institutionen

  • Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB T2N 4N1, Canada.
  • BC Cancer-Vancouver, Vancouver, BC V5Z 4E6, Canada.
  • Alberta Precision Laboratories, Calgary, AB T2N 4N1, Canada.
  • Department of Oncology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 1Z2, Canada.
  • Saskatchewan Cancer Agency, Saskatoon, SK S7N 4H4, Canada.
  • CancerCare Manitoba, Winnipeg, MB R2H 2A6, Canada.

ORCID-Profile: Sharlene Gill, Adrian Box, Shahid Ahmed, Christina Kim, Karen Mulder

Förderung

  • Amgen Canada
  • Astellas Pharma Canada
  • Bristol-Myers Squibb Canada
  • Daiichi-Sankyo Canada
  • Eisai Canada
  • Merck Canada
  • Pfizer Canada
  • Roche Canada

Zitieren

APA

Lee-Ying, R., Gill, S., Box, A., Latour, H., Strum, S., Gordon, V., Wong, R., Grendarova, P., Gimon, T., Ahmed, S., Geller, G., Kim, C., Le, D., Mulder, K., Paul, J., & Gowrishankar, B. (2026). Report from the 27th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Calgary, Alberta, 26–27 September 2025: Advances in Colon and Rectal Cancer. Current Oncology, 33(7), 437. https://doi.org/10.3390/curroncol33070437

Vancouver

Lee-Ying R, Gill S, Box A, Latour H, Strum S, Gordon V, et al. Report from the 27th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Calgary, Alberta, 26–27 September 2025: Advances in Colon and Rectal Cancer. Current Oncology. 2026;33(7):437. doi:10.3390/curroncol33070437

BibTeX
@article{LeeYing2026,
  author = {Lee-Ying, Richard and Gill, Sharlene and Box, Adrian and Latour, Hannah and Strum, Scott and Gordon, Vallerie and Wong, Ralph and Grendarova, Petra and Gimon, Tamara and Ahmed, Shahid and Geller, Georgia and Kim, Christina and Le, Duc and Mulder, Karen and Paul, James and Gowrishankar, Branawan},
  title = {Report from the 27th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Calgary, Alberta, 26–27 September 2025: Advances in Colon and Rectal Cancer},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {7},
  pages = {437},
  doi = {10.3390/curroncol33070437}
}
Kostenlos starten →